Affordable Access

deepdyve-link
Publisher Website

Societal value of stem cell therapy in stroke--a modeling study.

Authors
  • Svensson, Johanna
  • Ghatnekar, Ola
  • Lindgren, Arne
  • Lindvall, Olle
  • Norrving, Bo
  • Persson, Ulf
  • Kokaia, Zaal
Type
Published Article
Journal
Cerebrovascular Diseases
Publisher
S. Karger AG
Publication Date
Jan 01, 2012
Volume
33
Issue
6
Pages
532–539
Identifiers
DOI: 10.1159/000337765
PMID: 22571941
Source
Medline
License
Unknown

Abstract

The application of the health-economic model to Sweden shows that in younger stroke patients with moderate disability, the societal value of SCT given a zero price of stem cells is 166,500 USD. Although the transplantation itself is more costly, SCT offers potential for cost offset and cost savings in a long-term perspective by reducing the disability after stroke. The therapy appeared cost effective under a wide range of assumptions. Hence, further research and development in stem cells suitable for stroke therapy could potentially produce great value to society.

Report this publication

Statistics

Seen <100 times